Infection
Intensive care
PG13 Postgraduate Course
Inhaled antibiotics in respiratory infections
Translational
Registration for this session is additional to the congress registration fee and is €140 on site, €125 standard or €95 for early bird registration.
Aims : Access educational materials here
To provide an update on the use of inhaled antibiotics focusing on the evidence regarding their use in both acute and chronic respiratory infections; to delineate the areas of ongoing uncertainty and areas that require additional research.
Target audience :
Anaesthesiologist, Clinician, Emergency medicine doctor, Fellow, General practitioner, Intensivist/critical care physician, Junior member, Microbiologist, Nurse, Paediatrician, Patient, Pharmaceutical industry representative, Physiotherapist, Pulmonologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Student, TB specialist, Trainee
14:00
Inhaled antibiotics: strengths and fears
L. Palmer(Stony Brook, United States)
COI
-
Description
1
141
14:45
Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know
T. Welte(Hannover, Germany)
COI
-
Description
2
142
16:00
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
W. Boersma(Alkmaar, Netherlands)
COI
-
Description
4
144
16:45
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
M. Restrepo Montoya(San Antonio, United States)
COI
-
Description
5
145
. . .
